从关节到心脏的个人之旅。
A personal journey from the joint to the heart.
出版信息
Arthritis Res Ther. 2010;12(4):134. doi: 10.1186/ar3099. Epub 2010 Aug 13.
Abstract
Predicting complications of diseases such as rheumatoid arthritis (RA) as well as the efficacy and toxicity of drugs used to treat the disease based on an understanding of genetic differences is leading to the development of highly individualized, personal medicine. The prevention of cardiovascular complications of RA has assumed greater importance as our ability to treat the underlying joint disease has improved and it may be possible to predict which patients with RA are at greatest risk of developing cardiovascular disease.
摘要
基于对遗传差异的理解，预测类风湿关节炎 (RA) 等疾病的并发症以及用于治疗该疾病的药物的疗效和毒性，正引领着高度个体化、个性化医学的发展。随着我们治疗潜在关节疾病能力的提高，RA 的心血管并发症的预防变得更为重要，而且有可能预测出哪些 RA 患者面临最大的心血管疾病风险。
相似文献
1
A personal journey from the joint to the heart.从关节到心脏的个人之旅。
Arthritis Res Ther. 2010;12(4):134. doi: 10.1186/ar3099. Epub 2010 Aug 13.
2
Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.与系统性红斑狼疮和类风湿关节炎心血管疾病相关的新型基因变异。
Ann Rheum Dis. 2018 Jul;77(7):1063-1069. doi: 10.1136/annrheumdis-2017-212614. Epub 2018 Mar 7.
3
Lack of association between LEP rs2167270 (19 G>A) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis.LEP rs2167270（19 G>A）多态性与类风湿关节炎患者疾病易感性及心血管疾病之间缺乏关联。
Clin Exp Rheumatol. 2011 Mar-Apr;29(2):293-8. Epub 2011 Apr 19.
4
How twin studies help to understand inflammatory joint disease.双胞胎研究如何有助于理解炎性关节疾病。
Joint Bone Spine. 2016 Dec;83(6):637-643. doi: 10.1016/j.jbspin.2016.02.008. Epub 2016 Apr 7.
5
Human Leukocyte Antigen Shared Epitope and Inflammation, Cardiovascular Disease, Cancer, and Mortality Among Postmenopausal Women in the Women's Health Initiative Rheumatoid Arthritis Study.女性健康倡议类风湿关节炎研究中绝经后女性的人类白细胞抗原共享表位与炎症、心血管疾病、癌症及死亡率
Am J Epidemiol. 2017 Jul 15;186(2):245-254. doi: 10.1093/aje/kwx087.
6
Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis.分析生长激素释放肽受体rs509035、rs512692和rs2922126基因多态性对类风湿关节炎患者心血管疾病风险的影响。
Clin Exp Rheumatol. 2011 Jan-Feb;29(1):142-3. Epub 2011 Feb 23.
7
Polymorphisms of the genes encoding CD40 and growth differentiation factor 15 and in the 9p21.3 region in patients with rheumatoid arthritis and cardiovascular disease.CD40 和生长分化因子 15 基因编码区以及 9p21.3 区域的多态性与类风湿关节炎和心血管疾病患者有关。
J Rheumatol. 2012 May;39(5):939-45. doi: 10.3899/jrheum.111336. Epub 2012 Apr 15.
8
Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking.类风湿关节炎患者白细胞介素-6（IL-6）-174G/C基因多态性与心血管疾病的关联：肥胖和吸烟的作用
Atherosclerosis. 2009 May;204(1):178-83. doi: 10.1016/j.atherosclerosis.2008.08.036. Epub 2008 Sep 6.
9
Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis.白细胞介素 6 单核苷酸多态性与西班牙类风湿关节炎患者心血管疾病之间缺乏关联。
Atherosclerosis. 2011 Dec;219(2):655-8. doi: 10.1016/j.atherosclerosis.2011.07.124. Epub 2011 Aug 5.
10
Lack of association of PTPN22, STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis.PTPN22、STAT4 和 TRAF1/C5 基因多态性与类风湿关节炎心血管风险之间缺乏关联。
Clin Exp Rheumatol. 2010 Sep-Oct;28(5):695-701. Epub 2010 Oct 22.
本文引用的文献
1
The homocysteine controversy.同型半胱氨酸争议
J Inherit Metab Dis. 2011 Feb;34(1):93-9. doi: 10.1007/s10545-010-9151-1. Epub 2010 Jun 22.
2
A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis.MTHFR 基因中的 A1298C 多态性使类风湿关节炎患者易患心血管风险。
Arthritis Res Ther. 2010;12(2):R71. doi: 10.1186/ar2989. Epub 2010 Apr 26.
3
Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity.影响甲氨蝶呤毒性的亚甲基四氢叶酸还原酶（MTHFR）基因多态性的荟萃分析。
J Rheumatol. 2009 Mar;36(3):539-45. doi: 10.3899/jrheum.080576. Epub 2009 Feb 4.
4
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.甲氨蝶呤与类风湿关节炎患者的死亡率：一项前瞻性研究。
Lancet. 2002 Apr 6;359(9313):1173-7. doi: 10.1016/S0140-6736(02)08213-2.
5
A comprehensive review of genetic association studies.遗传关联研究的全面综述。
Genet Med. 2002 Mar-Apr;4(2):45-61. doi: 10.1097/00125817-200203000-00002.
6
Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.在类风湿关节炎的长期低剂量甲氨蝶呤治疗期间，补充叶酸可预防血液叶酸水平不足和高同型半胱氨酸血症：对预防心血管疾病的意义。
J Rheumatol. 1998 Mar;25(3):441-6.
7
Folate supplementation and methotrexate.叶酸补充剂与甲氨蝶呤
Ann Rheum Dis. 1993 Apr;52(4):315-6. doi: 10.1136/ard.52.4.315-b.
8
The mortality of rheumatoid arthritis.类风湿关节炎的死亡率
Arthritis Rheum. 1994 Apr;37(4):481-94. doi: 10.1002/art.1780370408.
9
Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial.类风湿关节炎甲氨蝶呤治疗期间补充叶酸。一项双盲、安慰剂对照试验。
Ann Intern Med. 1994 Dec 1;121(11):833-41. doi: 10.7326/0003-4819-121-11-199412010-00002.
10
Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexate.接受小剂量甲氨蝶呤治疗的类风湿关节炎患者的同型半胱氨酸水平
Clin Pharmacol Ther. 1991 Nov;50(5 Pt 1):547-56. doi: 10.1038/clpt.1991.180.
Zotero 插件